The genetic testing firm said the revenue growth was driven by a 37 percent increase in the number of billable tests delivered in the quarter.
Under the agreement, Expedeon will give Quanterix access to its CaptSure immunoassay products along with its Lightning-Link antibody labeling technology.
The company attributed the growth to increasing global demand for breast cancer testing, and growing demand and reimbursement for its prostate test.
The firm saw 60 percent revenue growth in molecular diagnostics, including 88 percent growth in its Solana system.
Myriad CEO Mark Capone said earnings during the quarter exceeded expectations based on strong volume growth from hereditary cancer and new products.
The NxClinical software integrates copy number, sequence variant, and allelic change information obtained from microarray and NGS technologies.
Researchers investigated the possibility of picking up intra-tumor genetic heterogeneity in tumor exomes, identifying false-positives and technical noise.
Stratec is producing the microfluidic chips for Vortex' VTX-1 system, which enables the enrichment and isolation of circulating tumor cells.
The firm's full fiscal year revenues were also up, 32 percent as reported, or about 6 percent on a currency-neutral basis.
A re-analysis of genomic tests for 309 children with epilepsy altered diagnoses for more than a third of patients with a previously reported genetic variant.
The partners said they have agreed to work together on projects in a range of diseases, as well as establish research alliances with groups in China and Africa.
Total revenues were down due to lower assay revenues, which shrank 11 percent from a year ago. Sample-to-answer molecular product revenues grew 15 percent.
Given that genetic susceptibility to schizophrenia is highly polygenic, the researchers found that the risk scores had some utility as prognostic biomarkers.
Stanford University's Michael Snyder found that methylome shifts preceded spikes in his blood glucose levels, suggesting profiling could detect disease.
Separate research groups have examined the genomes of modern and ancient Mongolian populations to study their ancestry, finding a relationship to Native Americans.
Researchers identified gene family expansions and other parasitic adaptations using genome sequences for 81 roundworms or flatworms.
Cytokine patterns could be useful as biomarkers for identifying pregnant women whose babies may be at risk of developing Zika-linked abnormalities.
Epic Sciences will donate its No Cell Left Behind platform to the clinical trial, which will enroll about 1,000 patients over three years.
Last week, GenomeWeb's readers were most interested in Illumina's plans to acquire Pacific Biosciences for approximately $1.2 billion in cash.
The award comes after DNAe completed the first phase of a contract valued at up to $51.9 million, which BARDA initiated in September 2016.
Simulated population data suggests that the lifetime risk of cervical cancer is lower for women who stop screening after a negative DNA test for oncogenic HPV.
An increase in sale growth for its life science segment was offset by a flat quarter year over year for its diagnostics sales.
Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.
DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.
As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.
In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.